Literature DB >> 15944911

The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.

F A M Baumeister1, D P Auer, K Hörtnagel, P Freisinger, T Meitinger.   

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome, is a rare autosomal recessive disorder characterized by extrapyramidal dysfunction as demonstrated by dystonia, rigidity, and choreoathetosis. Iron deposition in conjunction with destruction of the globus pallidus gives rise to the characteristic eye-of-the-tiger sign in MRI. It has been postulated that pantothenate kinase 2 mutations underlying all cases of classic Hallervorden-Spatz syndrome are always associated with the eye-of-the-tiger sign. Here, we report a patient with classic Hallervorden-Spatz syndrome and a homozygous pantothenate kinase 2 mutation in whom the initially present eye-of-the-tiger sign vanished during the course of the disease. Thus, the alleged one-to-one correlation between the eye-of-the-tiger sign and the presence of pantothenate kinase 2 mutation does not hold true over the course of the disease in PKAN.

Entities:  

Mesh:

Year:  2005        PMID: 15944911     DOI: 10.1055/s-2005-865714

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  10 in total

1.  Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without 'eye-of-the-tiger' sign on MRI in a pair of siblings.

Authors:  Zarazuela Zolkipli; Hisham Dahmoush; Dawn E Saunders; W K Kling Chong; Robert Surtees
Journal:  Pediatr Radiol       Date:  2006-06-07

Review 2.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 3.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 4.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

5.  Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia.

Authors:  Hormos Salimi Dafsari; Rosanne Sprute; Gilbert Wunderlich; Hülya-Sevcan Daimagüler; Ezgi Karaca; Adriana Contreras; Kerstin Becker; Mira Schulze-Rhonhof; Karl Kiening; Tülay Karakulak; Manja Kloss; Annette Horn; Amande Pauls; Peter Nürnberg; Janine Altmüller; Holger Thiele; Birgit Assmann; Anne Koy; Sebahattin Cirak
Journal:  J Hum Genet       Date:  2019-06-05       Impact factor: 3.172

Review 6.  Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases.

Authors:  M Tariq Bhatti
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

Review 7.  Neurological disorders presenting mainly in adolescence.

Authors:  S Macleod; R E Appleton
Journal:  Arch Dis Child       Date:  2007-02       Impact factor: 3.791

Review 8.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

Review 9.  Neuroimaging features of neurodegeneration with brain iron accumulation.

Authors:  M C Kruer; N Boddaert; S A Schneider; H Houlden; K P Bhatia; A Gregory; J C Anderson; W D Rooney; P Hogarth; S J Hayflick
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

Review 10.  Complex dystonias: an update on diagnosis and care.

Authors:  Rebecca Herzog; Anne Weissbach; Tobias Bäumer; Alexander Münchau
Journal:  J Neural Transm (Vienna)       Date:  2020-11-13       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.